The Enterprise Value as of December 2024 (TTM) for AN2 Therapeutics, Inc. (ANTX) is 8.33M

According to AN2 Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 8.33M. This represents a change of -95.35% compared to the average of 179.01M of the last 4 quarters.

AN2 Therapeutics, Inc. (ANTX) Historical Enterprise Value (quarterly & annually)

How has ANTX Enterprise Value performed in the past?

The mean historical Enterprise Value of AN2 Therapeutics, Inc. over the last ten years is 294.08M. The current 8.33M Enterprise Value has changed 183.14% with respect to the historical average. Over the past ten years (40 quarters), ANTX's Enterprise Value was at its highest in in the December 2023 quarter at 593.63M. The Enterprise Value was at its lowest in in the September 2024 quarter at -1573949.17.

AN2 Therapeutics, Inc. (ANTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of AN2 Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

AN2 Therapeutics, Inc. (ANTX) Average Enterprise Value

How has ANTX Enterprise Value performed in the past?

The current Enterprise Value of AN2 Therapeutics, Inc. (ANTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

AN2 Therapeutics, Inc. (ANTX) Enterprise Value vs. Peers

How is ANTX’s Enterprise Value compared to its peers?

AN2 Therapeutics, Inc.’s Enterprise Value is less than Aerovate Therapeutics, Inc. (43.34M), less than Adagene Inc. (8.35M), less than Acrivon Therapeutics, Inc. Common Stock (158.62M), less than Rezolute, Inc. (248.88M), less than Anebulo Pharmaceuticals, Inc. (31.01M), less than Mineralys Therapeutics, Inc. (502.94M), less than Molecular Partners AG (107.67M), less than Pharvaris N.V. (678.15M), less than PepGen Inc. (103.55M), less than PMV Pharmaceuticals, Inc. (42.60M), less than Eliem Therapeutics, Inc. (0), less than MediciNova, Inc. (61.90M),

Build a custom stock screener for AN2 Therapeutics, Inc. (ANTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AN2 Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AN2 Therapeutics, Inc. (ANTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AN2 Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.